Broken String Biosciences' technology platform, INDUCE-seq™, supports the development of cell and gene therapies that are safer by design. INDUCE-seq™ is an NGS-based DNA break mapping platform that enables companies developing cell and gene therapies to measure and quantify the specificity of off-target genetic edits and evaluate the associated genetic outcomes. The platform provides data-driven, actionable insights across the discovery, pre-clinical and clinical development stages to advance gene editing programs. 

Watch this video to learn more: